

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.03274763 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.03274763 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.75971168 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.75971168 |
| 5 | alpha-linolenic acid metabolic process (GO:0036109) | 5.60002178 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.56383256 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 5.10200935 |
| 8 | regulation of triglyceride catabolic process (GO:0010896) | 5.09500117 |
| 9 | * triglyceride biosynthetic process (GO:0019432) | 4.93730049 |
| 10 | brown fat cell differentiation (GO:0050873) | 4.91545329 |
| 11 | complement activation, alternative pathway (GO:0006957) | 4.87703453 |
| 12 | sulfur amino acid catabolic process (GO:0000098) | 4.85291595 |
| 13 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.83187382 |
| 14 | regulation of sequestering of triglyceride (GO:0010889) | 4.82966766 |
| 15 | * acylglycerol biosynthetic process (GO:0046463) | 4.73857454 |
| 16 | * neutral lipid biosynthetic process (GO:0046460) | 4.73857454 |
| 17 | fatty acid beta-oxidation (GO:0006635) | 4.69473532 |
| 18 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.68226658 |
| 19 | urea metabolic process (GO:0019627) | 4.58753330 |
| 20 | urea cycle (GO:0000050) | 4.58753330 |
| 21 | valine metabolic process (GO:0006573) | 4.57418695 |
| 22 | fatty acid transmembrane transport (GO:1902001) | 4.57122041 |
| 23 | acetyl-CoA metabolic process (GO:0006084) | 4.56347394 |
| 24 | triglyceride catabolic process (GO:0019433) | 4.56230919 |
| 25 | bile acid biosynthetic process (GO:0006699) | 4.55643573 |
| 26 | biotin metabolic process (GO:0006768) | 4.53394308 |
| 27 | glyoxylate metabolic process (GO:0046487) | 4.50708717 |
| 28 | neutral lipid catabolic process (GO:0046461) | 4.44951756 |
| 29 | acylglycerol catabolic process (GO:0046464) | 4.44951756 |
| 30 | lysine catabolic process (GO:0006554) | 4.42609663 |
| 31 | lysine metabolic process (GO:0006553) | 4.42609663 |
| 32 | cysteine metabolic process (GO:0006534) | 4.41278005 |
| 33 | fatty acid oxidation (GO:0019395) | 4.41273905 |
| 34 | * fatty acid homeostasis (GO:0055089) | 4.39200488 |
| 35 | positive regulation of lipid catabolic process (GO:0050996) | 4.36630088 |
| 36 | kynurenine metabolic process (GO:0070189) | 4.34943211 |
| 37 | * plasma lipoprotein particle clearance (GO:0034381) | 4.33649909 |
| 38 | lipid oxidation (GO:0034440) | 4.32695774 |
| 39 | fatty acid catabolic process (GO:0009062) | 4.32487131 |
| 40 | amino-acid betaine metabolic process (GO:0006577) | 4.31423769 |
| 41 | indole-containing compound catabolic process (GO:0042436) | 4.29828839 |
| 42 | indolalkylamine catabolic process (GO:0046218) | 4.29828839 |
| 43 | tryptophan catabolic process (GO:0006569) | 4.29828839 |
| 44 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 4.27370760 |
| 45 | nitrogen cycle metabolic process (GO:0071941) | 4.24939905 |
| 46 | high-density lipoprotein particle remodeling (GO:0034375) | 4.24758969 |
| 47 | positive regulation of fatty acid oxidation (GO:0046321) | 4.24341439 |
| 48 | * triglyceride homeostasis (GO:0070328) | 4.21115667 |
| 49 | * acylglycerol homeostasis (GO:0055090) | 4.21115667 |
| 50 | positive regulation of cholesterol efflux (GO:0010875) | 4.19786774 |
| 51 | * lipid storage (GO:0019915) | 4.19217311 |
| 52 | regulation of protein activation cascade (GO:2000257) | 4.18919351 |
| 53 | ethanol metabolic process (GO:0006067) | 4.13127192 |
| 54 | white fat cell differentiation (GO:0050872) | 4.13075998 |
| 55 | CDP-diacylglycerol metabolic process (GO:0046341) | 4.12689927 |
| 56 | positive regulation of lipid storage (GO:0010884) | 4.12614722 |
| 57 | carnitine shuttle (GO:0006853) | 4.12152723 |
| 58 | negative regulation of fibrinolysis (GO:0051918) | 4.11755564 |
| 59 | NADH metabolic process (GO:0006734) | 4.11573965 |
| 60 | linoleic acid metabolic process (GO:0043651) | 4.11348648 |
| 61 | * neutral lipid metabolic process (GO:0006638) | 4.07893165 |
| 62 | bile acid metabolic process (GO:0008206) | 4.07762530 |
| 63 | short-chain fatty acid metabolic process (GO:0046459) | 4.07223770 |
| 64 | serine family amino acid catabolic process (GO:0009071) | 4.05430931 |
| 65 | protein carboxylation (GO:0018214) | 4.04524230 |
| 66 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.04524230 |
| 67 | tryptophan metabolic process (GO:0006568) | 4.04020312 |
| 68 | monocarboxylic acid catabolic process (GO:0072329) | 4.01659109 |
| 69 | regulation of complement activation (GO:0030449) | 3.98067585 |
| 70 | 2-oxoglutarate metabolic process (GO:0006103) | 3.95411754 |
| 71 | negative regulation of phagocytosis (GO:0050765) | 3.94585196 |
| 72 | cellular ketone body metabolic process (GO:0046950) | 3.91717938 |
| 73 | regulation of fibrinolysis (GO:0051917) | 3.90188637 |
| 74 | * low-density lipoprotein particle clearance (GO:0034383) | 3.89801910 |
| 75 | reverse cholesterol transport (GO:0043691) | 3.89758937 |
| 76 | plasma lipoprotein particle remodeling (GO:0034369) | 3.89284796 |
| 77 | protein-lipid complex remodeling (GO:0034368) | 3.89284796 |
| 78 | macromolecular complex remodeling (GO:0034367) | 3.89284796 |
| 79 | branched-chain amino acid catabolic process (GO:0009083) | 3.89154919 |
| 80 | homocysteine metabolic process (GO:0050667) | 3.88742448 |
| 81 | alpha-amino acid catabolic process (GO:1901606) | 3.86963861 |
| 82 | tyrosine metabolic process (GO:0006570) | 3.84958663 |
| 83 | negative regulation of lipase activity (GO:0060192) | 3.83501990 |
| 84 | lipid particle organization (GO:0034389) | 3.81448046 |
| 85 | * diacylglycerol metabolic process (GO:0046339) | 3.80934560 |
| 86 | phospholipid homeostasis (GO:0055091) | 3.80261372 |
| 87 | * fatty-acyl-CoA metabolic process (GO:0035337) | 3.80094846 |
| 88 | regulation of cholesterol esterification (GO:0010872) | 3.79649336 |
| 89 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.79168840 |
| 90 | phospholipid efflux (GO:0033700) | 3.78756272 |
| 91 | ethanol oxidation (GO:0006069) | 3.75793689 |
| 92 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.74708235 |
| 93 | branched-chain amino acid metabolic process (GO:0009081) | 3.73782794 |
| 94 | thioester biosynthetic process (GO:0035384) | 3.72434375 |
| 95 | acyl-CoA biosynthetic process (GO:0071616) | 3.72434375 |
| 96 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.71643622 |
| 97 | carnitine metabolic process (GO:0009437) | 3.70357775 |
| 98 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.70119729 |
| 99 | negative regulation of granulocyte differentiation (GO:0030853) | 3.69615830 |
| 100 | cellular amino acid catabolic process (GO:0009063) | 3.69140356 |
| 101 | positive regulation of cholesterol transport (GO:0032376) | 3.67161215 |
| 102 | positive regulation of sterol transport (GO:0032373) | 3.67161215 |
| 103 | oxaloacetate metabolic process (GO:0006107) | 3.66395060 |
| 104 | * thioester metabolic process (GO:0035383) | 3.65892813 |
| 105 | * acyl-CoA metabolic process (GO:0006637) | 3.65892813 |
| 106 | aromatic amino acid family metabolic process (GO:0009072) | 3.65110005 |
| 107 | organic acid catabolic process (GO:0016054) | 3.64507868 |
| 108 | carboxylic acid catabolic process (GO:0046395) | 3.64507868 |
| 109 | negative regulation of protein autophosphorylation (GO:0031953) | 3.62220633 |
| 110 | tricarboxylic acid metabolic process (GO:0072350) | 3.60540987 |
| 111 | regulation of triglyceride metabolic process (GO:0090207) | 3.56865038 |
| 112 | regulation of fatty acid oxidation (GO:0046320) | 3.54951749 |
| 113 | response to phenylpropanoid (GO:0080184) | 3.53486897 |
| 114 | coenzyme catabolic process (GO:0009109) | 3.52733685 |
| 115 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.51964848 |
| 116 | * triglyceride metabolic process (GO:0006641) | 3.51784803 |
| 117 | polyol transport (GO:0015791) | 3.51343718 |
| 118 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.50387364 |
| 119 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.49775988 |
| 120 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.49775988 |
| 121 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.49470500 |
| 122 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.41647945 |
| 123 | * long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.41002011 |
| 124 | negative regulation of lipid catabolic process (GO:0050995) | 3.39517975 |
| 125 | * primary alcohol metabolic process (GO:0034308) | 3.39227558 |
| 126 | regulation of cholesterol storage (GO:0010885) | 3.37392120 |
| 127 | aspartate family amino acid catabolic process (GO:0009068) | 3.36511174 |
| 128 | ketone body metabolic process (GO:1902224) | 3.36285077 |
| 129 | carnitine transmembrane transport (GO:1902603) | 3.36213573 |
| 130 | negative regulation of sterol transport (GO:0032372) | 3.35924370 |
| 131 | negative regulation of cholesterol transport (GO:0032375) | 3.35924370 |
| 132 | cellular response to epinephrine stimulus (GO:0071872) | 3.33173185 |
| 133 | * acylglycerol metabolic process (GO:0006639) | 3.32836308 |
| 134 | cholesterol efflux (GO:0033344) | 3.32791660 |
| 135 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.32152233 |
| 136 | regulation of cholesterol metabolic process (GO:0090181) | 3.30122841 |
| 137 | glycerolipid catabolic process (GO:0046503) | 3.29219130 |
| 138 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.28983171 |
| 139 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.23848298 |
| 140 | regulation of lipid catabolic process (GO:0050994) | 3.19154968 |
| 141 | response to dietary excess (GO:0002021) | 3.18540690 |
| 142 | regulation of lipid storage (GO:0010883) | 3.13904495 |
| 143 | phosphatidic acid metabolic process (GO:0046473) | 3.13327729 |
| 144 | phosphatidic acid biosynthetic process (GO:0006654) | 3.13327729 |
| 145 | very long-chain fatty acid metabolic process (GO:0000038) | 3.12577906 |
| 146 | regulation of sterol transport (GO:0032371) | 3.09991424 |
| 147 | regulation of cholesterol transport (GO:0032374) | 3.09991424 |
| 148 | fatty acid elongation (GO:0030497) | 2.95732376 |
| 149 | cellular response to lithium ion (GO:0071285) | 2.92445886 |
| 150 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.91312172 |
| 151 | negative regulation of lipid storage (GO:0010888) | 2.90292622 |
| 152 | positive regulation of glomerulus development (GO:0090193) | 2.89820519 |
| 153 | detection of molecule of bacterial origin (GO:0032490) | 2.86481980 |
| 154 | protein heterotrimerization (GO:0070208) | 2.85217713 |
| 155 | transcytosis (GO:0045056) | 2.85002717 |
| 156 | L-serine transport (GO:0015825) | 2.82150781 |
| 157 | positive regulation of glycolytic process (GO:0045821) | 2.82141641 |
| 158 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.79769686 |
| 159 | response to epinephrine (GO:0071871) | 2.75778643 |
| 160 | primary alcohol catabolic process (GO:0034310) | 2.75573252 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.22262426 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 9.03713193 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.75898727 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.81243728 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.45262708 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.74797567 |
| 7 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.26898485 |
| 8 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.86179957 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.64537677 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.55517221 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.56704302 |
| 12 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.52473974 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.23081392 |
| 14 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.72808660 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 1.51336700 |
| 16 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.51110941 |
| 17 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.50617038 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49002481 |
| 19 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.48177391 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.42727458 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.42686839 |
| 22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.39544194 |
| 23 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.33697339 |
| 24 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.33409095 |
| 25 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.32324285 |
| 26 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.32139632 |
| 27 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.32023544 |
| 28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.31664990 |
| 29 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.29994887 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.29393016 |
| 31 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.28854694 |
| 32 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.28718111 |
| 33 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.26671824 |
| 34 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.24100245 |
| 35 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.23529958 |
| 36 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.22142878 |
| 37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.19625248 |
| 38 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19037542 |
| 39 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.17434424 |
| 40 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.16307377 |
| 41 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16070946 |
| 42 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.13881212 |
| 43 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.13196565 |
| 44 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12980299 |
| 45 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.12800353 |
| 46 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.08854010 |
| 47 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08062962 |
| 48 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.07575339 |
| 49 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.07164067 |
| 50 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.07085132 |
| 51 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.06522331 |
| 52 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.06356529 |
| 53 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06137742 |
| 54 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05966122 |
| 55 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.04111717 |
| 56 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.01485558 |
| 57 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00271140 |
| 58 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.99425778 |
| 59 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.99119005 |
| 60 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.98364644 |
| 61 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.97726734 |
| 62 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95551570 |
| 63 | P68_20966046_ChIP-Seq_HELA_Human | 0.94584612 |
| 64 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.93908151 |
| 65 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.93008879 |
| 66 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.92524168 |
| 67 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.92228076 |
| 68 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.91465350 |
| 69 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.91356491 |
| 70 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.90324242 |
| 71 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.88904324 |
| 72 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.88666916 |
| 73 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.88594805 |
| 74 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.88527006 |
| 75 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.88319795 |
| 76 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.87528708 |
| 77 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.87355876 |
| 78 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.86314325 |
| 79 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.85853851 |
| 80 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.85646936 |
| 81 | * SPI1_23127762_ChIP-Seq_K562_Human | 0.85175893 |
| 82 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.84495671 |
| 83 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.84495671 |
| 84 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.83182254 |
| 85 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.83182254 |
| 86 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82617243 |
| 87 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.81425746 |
| 88 | MAF_26560356_Chip-Seq_TH1_Human | 0.81406324 |
| 89 | MAF_26560356_Chip-Seq_TH2_Human | 0.80861772 |
| 90 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80831425 |
| 91 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.80595278 |
| 92 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80515374 |
| 93 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79024695 |
| 94 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.78850229 |
| 95 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78798777 |
| 96 | KDM2B_26808549_Chip-Seq_K562_Human | 0.78162154 |
| 97 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.78120360 |
| 98 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77683345 |
| 99 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.77550586 |
| 100 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76675132 |
| 101 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76277131 |
| 102 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.75980420 |
| 103 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.75889250 |
| 104 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.75357919 |
| 105 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73858761 |
| 106 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.72719051 |
| 107 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.71501951 |
| 108 | GATA1_19941826_ChIP-Seq_K562_Human | 0.70519565 |
| 109 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.69707716 |
| 110 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.69193471 |
| 111 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.69021466 |
| 112 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.68616103 |
| 113 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.67263776 |
| 114 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.67084920 |
| 115 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.66590801 |
| 116 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.65122042 |
| 117 | GATA2_19941826_ChIP-Seq_K562_Human | 0.63915673 |
| 118 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.63448683 |
| 119 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.62088708 |
| 120 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.61572532 |
| 121 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.60928799 |
| 122 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.60465819 |
| 123 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.60241827 |
| 124 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.57549854 |
| 125 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.56936324 |
| 126 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.55724690 |
| 127 | CBP_21632823_ChIP-Seq_H3396_Human | 0.55319447 |
| 128 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.55142273 |
| 129 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.54643359 |
| 130 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.54444767 |
| 131 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.54009442 |
| 132 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.53953627 |
| 133 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.53860319 |
| 134 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.53323374 |
| 135 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.52341344 |
| 136 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51164885 |
| 137 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.50317113 |
| 138 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.50021276 |
| 139 | * BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.49912338 |
| 140 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.49010864 |
| 141 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.48941592 |
| 142 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.48275660 |
| 143 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.47806514 |
| 144 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.47140466 |
| 145 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47110984 |
| 146 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.46814048 |
| 147 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.46458172 |
| 148 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.46036247 |
| 149 | RXR_22108803_ChIP-Seq_LS180_Human | 0.45812593 |
| 150 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.45430411 |
| 151 | CJUN_26792858_Chip-Seq_BT549_Human | 0.45315200 |
| 152 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.44714114 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.57508187 |
| 2 | MP0005360_urolithiasis | 6.15443404 |
| 3 | MP0005365_abnormal_bile_salt | 5.07043074 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.80612504 |
| 5 | MP0005670_abnormal_white_adipose | 4.23296659 |
| 6 | MP0010329_abnormal_lipoprotein_level | 3.94187110 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.82884067 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 2.93712164 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 2.91401495 |
| 10 | MP0003252_abnormal_bile_duct | 2.89253926 |
| 11 | MP0005666_abnormal_adipose_tissue | 2.89164032 |
| 12 | MP0004130_abnormal_muscle_cell | 2.86264557 |
| 13 | MP0009840_abnormal_foam_cell | 2.61994645 |
| 14 | MP0002837_dystrophic_cardiac_calcinosis | 2.58673826 |
| 15 | * MP0002118_abnormal_lipid_homeostasis | 2.50389020 |
| 16 | MP0005332_abnormal_amino_acid | 2.47682314 |
| 17 | MP0004185_abnormal_adipocyte_glucose | 2.29988368 |
| 18 | MP0003828_pulmonary_edema | 2.15653670 |
| 19 | MP0000609_abnormal_liver_physiology | 2.14838417 |
| 20 | MP0001666_abnormal_nutrient_absorption | 2.12561162 |
| 21 | MP0002971_abnormal_brown_adipose | 2.06530096 |
| 22 | MP0002876_abnormal_thyroid_physiology | 1.94820088 |
| 23 | MP0005083_abnormal_biliary_tract | 1.94641014 |
| 24 | MP0005375_adipose_tissue_phenotype | 1.94364572 |
| 25 | MP0003195_calcinosis | 1.90482804 |
| 26 | MP0004019_abnormal_vitamin_homeostasis | 1.74520789 |
| 27 | MP0005319_abnormal_enzyme/_coenzyme | 1.74147424 |
| 28 | MP0005334_abnormal_fat_pad | 1.63935908 |
| 29 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.63875907 |
| 30 | MP0003705_abnormal_hypodermis_morpholog | 1.63106268 |
| 31 | MP0001764_abnormal_homeostasis | 1.53087578 |
| 32 | MP0008438_abnormal_cutaneous_collagen | 1.45079532 |
| 33 | MP0009115_abnormal_fat_cell | 1.44382616 |
| 34 | MP0003436_decreased_susceptibility_to | 1.41994734 |
| 35 | MP0001661_extended_life_span | 1.41947503 |
| 36 | MP0003186_abnormal_redox_activity | 1.41509419 |
| 37 | MP0000343_altered_response_to | 1.41105981 |
| 38 | * MP0005535_abnormal_body_temperature | 1.33037785 |
| 39 | MP0005451_abnormal_body_composition | 1.32616975 |
| 40 | MP0005164_abnormal_response_to | 1.30325488 |
| 41 | MP0002254_reproductive_system_inflammat | 1.29063538 |
| 42 | MP0003303_peritoneal_inflammation | 1.28283336 |
| 43 | MP0009643_abnormal_urine_homeostasis | 1.26551145 |
| 44 | MP0003690_abnormal_glial_cell | 1.25679018 |
| 45 | MP0006036_abnormal_mitochondrial_physio | 1.24976253 |
| 46 | MP0005275_abnormal_skin_tensile | 1.21314014 |
| 47 | MP0000013_abnormal_adipose_tissue | 1.20194904 |
| 48 | MP0005448_abnormal_energy_balance | 1.18465265 |
| 49 | * MP0002078_abnormal_glucose_homeostasis | 1.16126778 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.12824246 |
| 51 | MP0000003_abnormal_adipose_tissue | 1.11270762 |
| 52 | MP0004381_abnormal_hair_follicle | 1.10986548 |
| 53 | MP0002419_abnormal_innate_immunity | 1.10611904 |
| 54 | MP0002132_abnormal_respiratory_system | 1.08667814 |
| 55 | MP0009785_altered_susceptibility_to | 1.08412669 |
| 56 | MP0000604_amyloidosis | 1.07171638 |
| 57 | * MP0002970_abnormal_white_adipose | 1.07114123 |
| 58 | MP0003011_delayed_dark_adaptation | 1.06159793 |
| 59 | MP0000858_altered_metastatic_potential | 1.04448874 |
| 60 | MP0003868_abnormal_feces_composition | 1.02304665 |
| 61 | MP0003300_gastrointestinal_ulcer | 1.02040067 |
| 62 | MP0005647_abnormal_sex_gland | 1.01113102 |
| 63 | MP0002138_abnormal_hepatobiliary_system | 0.95821713 |
| 64 | MP0000598_abnormal_liver_morphology | 0.94483186 |
| 65 | MP0003646_muscle_fatigue | 0.93649111 |
| 66 | MP0004883_abnormal_blood_vessel | 0.91593623 |
| 67 | MP0009763_increased_sensitivity_to | 0.90987428 |
| 68 | MP0004947_skin_inflammation | 0.89498008 |
| 69 | MP0005025_abnormal_response_to | 0.88505318 |
| 70 | MP0000249_abnormal_blood_vessel | 0.88229451 |
| 71 | MP0003959_abnormal_lean_body | 0.87833598 |
| 72 | MP0009697_abnormal_copulation | 0.85381427 |
| 73 | MP0003329_amyloid_beta_deposits | 0.85237159 |
| 74 | MP0000685_abnormal_immune_system | 0.84593950 |
| 75 | MP0001756_abnormal_urination | 0.83918636 |
| 76 | MP0003656_abnormal_erythrocyte_physiolo | 0.82638380 |
| 77 | MP0001851_eye_inflammation | 0.81527587 |
| 78 | MP0003948_abnormal_gas_homeostasis | 0.79093158 |
| 79 | * MP0009642_abnormal_blood_homeostasis | 0.77614277 |
| 80 | MP0005330_cardiomyopathy | 0.75756937 |
| 81 | MP0005397_hematopoietic_system_phenotyp | 0.74705761 |
| 82 | MP0001545_abnormal_hematopoietic_system | 0.74705761 |
| 83 | * MP0002796_impaired_skin_barrier | 0.74218361 |
| 84 | MP0006138_congestive_heart_failure | 0.72853841 |
| 85 | MP0010234_abnormal_vibrissa_follicle | 0.72593172 |
| 86 | MP0009764_decreased_sensitivity_to | 0.72412951 |
| 87 | MP0005376_homeostasis/metabolism_phenot | 0.71841403 |
| 88 | MP0003724_increased_susceptibility_to | 0.70401282 |
| 89 | MP0010368_abnormal_lymphatic_system | 0.69032308 |
| 90 | MP0005266_abnormal_metabolism | 0.68877458 |
| 91 | MP0005000_abnormal_immune_tolerance | 0.68876995 |
| 92 | * MP0005452_abnormal_adipose_tissue | 0.68677624 |
| 93 | MP0002933_joint_inflammation | 0.67877536 |
| 94 | MP0003953_abnormal_hormone_level | 0.67808167 |
| 95 | MP0005636_abnormal_mineral_homeostasis | 0.67771586 |
| 96 | MP0002822_catalepsy | 0.66740675 |
| 97 | MP0001790_abnormal_immune_system | 0.66249228 |
| 98 | MP0005387_immune_system_phenotype | 0.66249228 |
| 99 | MP0002060_abnormal_skin_morphology | 0.65578705 |
| 100 | MP0003453_abnormal_keratinocyte_physiol | 0.64630337 |
| 101 | MP0001881_abnormal_mammary_gland | 0.64520084 |
| 102 | MP0008469_abnormal_protein_level | 0.63969642 |
| 103 | MP0005595_abnormal_vascular_smooth | 0.63486955 |
| 104 | MP0005058_abnormal_lysosome_morphology | 0.63062313 |
| 105 | MP0004782_abnormal_surfactant_physiolog | 0.62599064 |
| 106 | MP0000230_abnormal_systemic_arterial | 0.61353535 |
| 107 | MP0008260_abnormal_autophagy | 0.60370637 |
| 108 | MP0005379_endocrine/exocrine_gland_phen | 0.59394669 |
| 109 | MP0005385_cardiovascular_system_phenoty | 0.58195879 |
| 110 | MP0001544_abnormal_cardiovascular_syste | 0.58195879 |
| 111 | MP0009765_abnormal_xenobiotic_induced | 0.57616376 |
| 112 | MP0003566_abnormal_cell_adhesion | 0.57109711 |
| 113 | MP0002108_abnormal_muscle_morphology | 0.56831041 |
| 114 | MP0000751_myopathy | 0.56809803 |
| 115 | MP0002148_abnormal_hypersensitivity_rea | 0.55703458 |
| 116 | MP0001800_abnormal_humoral_immune | 0.55566601 |
| 117 | MP0005388_respiratory_system_phenotype | 0.55387590 |
| 118 | MP0002133_abnormal_respiratory_system | 0.55387590 |
| 119 | MP0008775_abnormal_heart_ventricle | 0.55368744 |
| 120 | MP0002638_abnormal_pupillary_reflex | 0.55221456 |
| 121 | MP0002909_abnormal_adrenal_gland | 0.55003850 |
| 122 | MP0009780_abnormal_chondrocyte_physiolo | 0.54554746 |
| 123 | MP0004087_abnormal_muscle_fiber | 0.52499490 |
| 124 | MP0005620_abnormal_muscle_contractility | 0.52352578 |
| 125 | MP0002332_abnormal_exercise_endurance | 0.50561749 |
| 126 | MP0004147_increased_porphyrin_level | 0.50109486 |
| 127 | MP0003075_altered_response_to | 0.49743045 |
| 128 | MP0006035_abnormal_mitochondrial_morpho | 0.49648372 |
| 129 | MP0004215_abnormal_myocardial_fiber | 0.49217743 |
| 130 | MP0002168_other_aberrant_phenotype | 0.48673393 |
| 131 | MP0002269_muscular_atrophy | 0.48351216 |
| 132 | MP0004272_abnormal_basement_membrane | 0.48348892 |
| 133 | MP0008874_decreased_physiological_sensi | 0.47374319 |
| 134 | MP0005084_abnormal_gallbladder_morpholo | 0.47370663 |
| 135 | MP0002136_abnormal_kidney_physiology | 0.46665176 |
| 136 | MP0008961_abnormal_basal_metabolism | 0.45214185 |
| 137 | MP0005167_abnormal_blood-brain_barrier | 0.44439871 |
| 138 | MP0000427_abnormal_hair_cycle | 0.42963189 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.68998489 |
| 2 | Xanthomatosis (HP:0000991) | 5.59692221 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.41513854 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 5.36375826 |
| 5 | Hyperglycinuria (HP:0003108) | 5.36153406 |
| 6 | Hyperlipoproteinemia (HP:0010980) | 5.14788689 |
| 7 | Complement deficiency (HP:0004431) | 5.02831398 |
| 8 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.92306044 |
| 9 | Abnormality of glycine metabolism (HP:0010895) | 4.92306044 |
| 10 | Hyperammonemia (HP:0001987) | 4.67405280 |
| 11 | Ketosis (HP:0001946) | 4.65586390 |
| 12 | Hypobetalipoproteinemia (HP:0003563) | 4.64302976 |
| 13 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.60967168 |
| 14 | Prolonged partial thromboplastin time (HP:0003645) | 4.52229849 |
| 15 | Hyperglycinemia (HP:0002154) | 4.43008492 |
| 16 | Epidermoid cyst (HP:0200040) | 4.40533463 |
| 17 | Hypoalphalipoproteinemia (HP:0003233) | 4.39762247 |
| 18 | Hypoglycemic coma (HP:0001325) | 4.37833517 |
| 19 | Hypolipoproteinemia (HP:0010981) | 4.26857606 |
| 20 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.18930425 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.16907788 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.91641582 |
| 23 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.89544901 |
| 24 | Ketoacidosis (HP:0001993) | 3.85871206 |
| 25 | Eczematoid dermatitis (HP:0000976) | 3.81631216 |
| 26 | Difficulty running (HP:0009046) | 3.57904565 |
| 27 | Abnormality of complement system (HP:0005339) | 3.57803237 |
| 28 | Hypercholesterolemia (HP:0003124) | 3.45031748 |
| 29 | Orchitis (HP:0100796) | 3.41130518 |
| 30 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.37028047 |
| 31 | Dicarboxylic aciduria (HP:0003215) | 3.37028047 |
| 32 | Increased IgE level (HP:0003212) | 3.35907957 |
| 33 | Oligomenorrhea (HP:0000876) | 3.32802355 |
| 34 | Joint hemorrhage (HP:0005261) | 3.29868756 |
| 35 | Hypertriglyceridemia (HP:0002155) | 3.29519986 |
| 36 | Abnormality of the common coagulation pathway (HP:0010990) | 3.28189321 |
| 37 | Myositis (HP:0100614) | 3.27420623 |
| 38 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.26498579 |
| 39 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.14261766 |
| 40 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.13192697 |
| 41 | Increased variability in muscle fiber diameter (HP:0003557) | 3.11352976 |
| 42 | Myoglobinuria (HP:0002913) | 3.04487110 |
| 43 | Acanthosis nigricans (HP:0000956) | 3.03733132 |
| 44 | Myocardial infarction (HP:0001658) | 2.97376942 |
| 45 | Abnormality of methionine metabolism (HP:0010901) | 2.96888433 |
| 46 | Abnormality of serum amino acid levels (HP:0003112) | 2.95081614 |
| 47 | Skin nodule (HP:0200036) | 2.91953687 |
| 48 | Retrobulbar optic neuritis (HP:0100654) | 2.91617757 |
| 49 | Optic neuritis (HP:0100653) | 2.91617757 |
| 50 | Fat malabsorption (HP:0002630) | 2.89656558 |
| 51 | Growth hormone excess (HP:0000845) | 2.87941251 |
| 52 | Polycythemia (HP:0001901) | 2.87517559 |
| 53 | Abnormal hemoglobin (HP:0011902) | 2.83241407 |
| 54 | Metabolic acidosis (HP:0001942) | 2.82411546 |
| 55 | Hydroxyprolinuria (HP:0003080) | 2.81913769 |
| 56 | Abnormality of proline metabolism (HP:0010907) | 2.81913769 |
| 57 | Increased serum pyruvate (HP:0003542) | 2.76616514 |
| 58 | Abnormality of the intrinsic pathway (HP:0010989) | 2.73227563 |
| 59 | Lethargy (HP:0001254) | 2.72747165 |
| 60 | Abnormality of purine metabolism (HP:0004352) | 2.70441567 |
| 61 | Delayed CNS myelination (HP:0002188) | 2.64202016 |
| 62 | Cerebral edema (HP:0002181) | 2.63134266 |
| 63 | Hemorrhage of the eye (HP:0011885) | 2.62520906 |
| 64 | Gingivitis (HP:0000230) | 2.60245188 |
| 65 | Bone cyst (HP:0012062) | 2.57255570 |
| 66 | Keratoconjunctivitis sicca (HP:0001097) | 2.53284895 |
| 67 | Hyperbilirubinemia (HP:0002904) | 2.52127053 |
| 68 | Long foot (HP:0001833) | 2.51712497 |
| 69 | Pancreatitis (HP:0001733) | 2.51537712 |
| 70 | Abnormality of nucleobase metabolism (HP:0010932) | 2.51499882 |
| 71 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.50784118 |
| 72 | Vertebral compression fractures (HP:0002953) | 2.47964919 |
| 73 | Generalized aminoaciduria (HP:0002909) | 2.47810170 |
| 74 | Prolonged bleeding time (HP:0003010) | 2.45877752 |
| 75 | Protrusio acetabuli (HP:0003179) | 2.44728524 |
| 76 | Conjugated hyperbilirubinemia (HP:0002908) | 2.44463547 |
| 77 | Systemic lupus erythematosus (HP:0002725) | 2.44070794 |
| 78 | Rhabdomyolysis (HP:0003201) | 2.41518055 |
| 79 | Gastrointestinal infarctions (HP:0005244) | 2.40748002 |
| 80 | Peritonitis (HP:0002586) | 2.38950546 |
| 81 | Recurrent abscess formation (HP:0002722) | 2.33316255 |
| 82 | Hypoglycemic seizures (HP:0002173) | 2.33158791 |
| 83 | Vomiting (HP:0002013) | 2.32970652 |
| 84 | Abnormality of alanine metabolism (HP:0010916) | 2.32862372 |
| 85 | Hyperalaninemia (HP:0003348) | 2.32862372 |
| 86 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.32862372 |
| 87 | Abnormality of glycolysis (HP:0004366) | 2.32824236 |
| 88 | Nausea (HP:0002018) | 2.29227530 |
| 89 | Amyloidosis (HP:0011034) | 2.28272778 |
| 90 | Axonal loss (HP:0003447) | 2.27192931 |
| 91 | Keratoconjunctivitis (HP:0001096) | 2.26841709 |
| 92 | Brushfield spots (HP:0001088) | 2.26496519 |
| 93 | Abnormal gallbladder morphology (HP:0012437) | 2.26174552 |
| 94 | Cholelithiasis (HP:0001081) | 2.25819545 |
| 95 | Hepatosplenomegaly (HP:0001433) | 2.23419464 |
| 96 | Colitis (HP:0002583) | 2.22429662 |
| 97 | Abnormality of macrophages (HP:0004311) | 2.22307987 |
| 98 | Increased muscle lipid content (HP:0009058) | 2.21557453 |
| 99 | Hepatocellular carcinoma (HP:0001402) | 2.20225013 |
| 100 | Abnormal platelet volume (HP:0011876) | 2.18960540 |
| 101 | Abnormal cartilage morphology (HP:0002763) | 2.16899753 |
| 102 | Hyperglycemia (HP:0003074) | 2.13874703 |
| 103 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.13616513 |
| 104 | Cholecystitis (HP:0001082) | 2.13167369 |
| 105 | Abnormal gallbladder physiology (HP:0012438) | 2.13167369 |
| 106 | Back pain (HP:0003418) | 2.13000240 |
| 107 | Gingival bleeding (HP:0000225) | 2.10772366 |
| 108 | Spontaneous abortion (HP:0005268) | 2.09211348 |
| 109 | Ectopia lentis (HP:0001083) | 2.09122417 |
| 110 | Gout (HP:0001997) | 2.08503765 |
| 111 | Pigmentary retinal degeneration (HP:0001146) | 2.08317040 |
| 112 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.07025847 |
| 113 | Right ventricular cardiomyopathy (HP:0011663) | 2.06782285 |
| 114 | Conjunctival hamartoma (HP:0100780) | 2.06371232 |
| 115 | Hypercortisolism (HP:0001578) | 2.06192816 |
| 116 | Steatorrhea (HP:0002570) | 2.02685812 |
| 117 | Sensorimotor neuropathy (HP:0007141) | 2.01323448 |
| 118 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.01178011 |
| 119 | Cupped ribs (HP:0000887) | 2.00835883 |
| 120 | Polyphagia (HP:0002591) | 2.00801007 |
| 121 | Toxemia of pregnancy (HP:0100603) | 2.00357747 |
| 122 | Insulin resistance (HP:0000855) | 2.00231354 |
| 123 | Acute hepatic failure (HP:0006554) | 2.00032148 |
| 124 | Subcapsular cataract (HP:0000523) | 1.99100196 |
| 125 | Recurrent bacterial skin infections (HP:0005406) | 1.98939657 |
| 126 | Acanthocytosis (HP:0001927) | 1.97796061 |
| 127 | Neonatal onset (HP:0003623) | 1.97137597 |
| 128 | Irritability (HP:0000737) | 1.96954429 |
| 129 | Rickets (HP:0002748) | 1.96274672 |
| 130 | Proximal tubulopathy (HP:0000114) | 1.95480379 |
| 131 | Increased purine levels (HP:0004368) | 1.94678377 |
| 132 | Hyperuricemia (HP:0002149) | 1.94678377 |
| 133 | Short nail (HP:0001799) | 1.94635897 |
| 134 | Glomerulopathy (HP:0100820) | 1.94374703 |
| 135 | Late onset (HP:0003584) | 1.93946956 |
| 136 | Renal cortical cysts (HP:0000803) | 1.93621310 |
| 137 | Gangrene (HP:0100758) | 1.93496517 |
| 138 | Polygenic inheritance (HP:0010982) | 1.92884812 |
| 139 | Abnormal eating behavior (HP:0100738) | 1.91121911 |
| 140 | Spastic diplegia (HP:0001264) | 1.91086754 |
| 141 | Vascular calcification (HP:0004934) | 1.90866700 |
| 142 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.90415951 |
| 143 | Spontaneous hematomas (HP:0007420) | 1.88033957 |
| 144 | Increased mean platelet volume (HP:0011877) | 1.87411866 |
| 145 | Hepatic necrosis (HP:0002605) | 1.85776505 |
| 146 | Malnutrition (HP:0004395) | 1.85121616 |
| 147 | Pathologic fracture (HP:0002756) | 1.84908347 |
| 148 | Inflammation of the large intestine (HP:0002037) | 1.84658733 |
| 149 | Easy fatigability (HP:0003388) | 1.81641711 |
| 150 | Abnormality of carpal bone ossification (HP:0006257) | 1.81407259 |
| 151 | Nephritis (HP:0000123) | 1.81255104 |
| 152 | Stomatitis (HP:0010280) | 1.81230254 |
| 153 | Cardiovascular calcification (HP:0011915) | 1.79343717 |
| 154 | Prominent supraorbital ridges (HP:0000336) | 1.78974025 |
| 155 | Ovoid vertebral bodies (HP:0003300) | 1.78358678 |
| 156 | Elevated hepatic transaminases (HP:0002910) | 1.77036200 |
| 157 | Abnormality of the gallbladder (HP:0005264) | 1.75541365 |
| 158 | Mitral stenosis (HP:0001718) | 1.75516613 |
| 159 | Glomerulonephritis (HP:0000099) | 1.74628579 |
| 160 | Hypochromic microcytic anemia (HP:0004840) | 1.70780561 |
| 161 | Esophageal varix (HP:0002040) | 1.70739059 |
| 162 | Enlarged kidneys (HP:0000105) | 1.69035619 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.30672763 |
| 2 | SIK1 | 4.47344567 |
| 3 | CAMK1D | 3.96185871 |
| 4 | TRIB3 | 3.91902377 |
| 5 | RIPK4 | 3.26504986 |
| 6 | ERN1 | 2.97915182 |
| 7 | CAMK1G | 2.83732735 |
| 8 | PDK3 | 2.77121598 |
| 9 | PDK4 | 2.77121598 |
| 10 | FGFR4 | 2.59476879 |
| 11 | INSRR | 2.46664662 |
| 12 | MST1R | 2.43607015 |
| 13 | PRPF4B | 1.99736140 |
| 14 | LMTK2 | 1.95524519 |
| 15 | BLK | 1.77449872 |
| 16 | PRKAA2 | 1.77022133 |
| 17 | TNK2 | 1.67949648 |
| 18 | PKN2 | 1.67532800 |
| 19 | FGFR2 | 1.61234592 |
| 20 | RIPK1 | 1.60970666 |
| 21 | PDK2 | 1.58464980 |
| 22 | FRK | 1.53360734 |
| 23 | ZAP70 | 1.52415879 |
| 24 | IRAK4 | 1.46496732 |
| 25 | MAP2K4 | 1.45909440 |
| 26 | LATS1 | 1.45435790 |
| 27 | PINK1 | 1.41473486 |
| 28 | MAP3K1 | 1.41110466 |
| 29 | MAP4K1 | 1.40906235 |
| 30 | JAK3 | 1.37913739 |
| 31 | FES | 1.36687979 |
| 32 | MAP3K11 | 1.30816490 |
| 33 | ERBB4 | 1.20486162 |
| 34 | MAPK11 | 1.20385535 |
| 35 | TESK1 | 1.19624963 |
| 36 | TAOK1 | 1.07563644 |
| 37 | DDR2 | 1.06383846 |
| 38 | TTN | 1.05548243 |
| 39 | PDPK1 | 1.04583611 |
| 40 | TIE1 | 1.03517566 |
| 41 | PIK3CA | 1.03258930 |
| 42 | DAPK2 | 1.01787415 |
| 43 | PRKAA1 | 1.01638890 |
| 44 | MET | 0.98958994 |
| 45 | HCK | 0.97126885 |
| 46 | JAK1 | 0.96261356 |
| 47 | CAMKK2 | 0.96020593 |
| 48 | PHKG2 | 0.95946389 |
| 49 | PHKG1 | 0.95946389 |
| 50 | FGFR3 | 0.94964405 |
| 51 | EPHA4 | 0.94732679 |
| 52 | JAK2 | 0.94526888 |
| 53 | YES1 | 0.92518030 |
| 54 | ABL2 | 0.90706958 |
| 55 | EPHB1 | 0.89575830 |
| 56 | KIT | 0.89180122 |
| 57 | MARK2 | 0.88837179 |
| 58 | MAP2K1 | 0.88088891 |
| 59 | NLK | 0.87832566 |
| 60 | NEK9 | 0.87666553 |
| 61 | MAP3K7 | 0.86752773 |
| 62 | MAP3K13 | 0.86154580 |
| 63 | FLT3 | 0.84785783 |
| 64 | PTK6 | 0.84736302 |
| 65 | MYLK | 0.84434476 |
| 66 | PIK3CG | 0.84077339 |
| 67 | PRKACG | 0.83160536 |
| 68 | BTK | 0.82611982 |
| 69 | ICK | 0.82398963 |
| 70 | PRKD2 | 0.79143540 |
| 71 | PDK1 | 0.78058083 |
| 72 | CDK6 | 0.77825748 |
| 73 | TAOK3 | 0.75670075 |
| 74 | IRAK1 | 0.70400228 |
| 75 | MAP3K6 | 0.69913668 |
| 76 | MAP2K3 | 0.69567812 |
| 77 | MAP3K3 | 0.68375029 |
| 78 | MAPK12 | 0.68101678 |
| 79 | OBSCN | 0.67832472 |
| 80 | PDGFRA | 0.67187167 |
| 81 | GRK5 | 0.65944961 |
| 82 | FER | 0.63528590 |
| 83 | GSK3A | 0.63261722 |
| 84 | EPHB2 | 0.62849630 |
| 85 | PTK2B | 0.62055618 |
| 86 | TYK2 | 0.61852959 |
| 87 | ADRBK1 | 0.60612655 |
| 88 | RAF1 | 0.60016549 |
| 89 | KSR2 | 0.59061516 |
| 90 | RET | 0.58753001 |
| 91 | PRKCZ | 0.58559858 |
| 92 | TAOK2 | 0.58417706 |
| 93 | SYK | 0.56454914 |
| 94 | LYN | 0.55792911 |
| 95 | PDGFRB | 0.55289768 |
| 96 | PRKCH | 0.54336127 |
| 97 | MAPK4 | 0.53628936 |
| 98 | TGFBR2 | 0.53309302 |
| 99 | LCK | 0.52973571 |
| 100 | MAPK7 | 0.52861219 |
| 101 | FGR | 0.51825936 |
| 102 | ARAF | 0.51409265 |
| 103 | KDR | 0.51354365 |
| 104 | PRKD1 | 0.51040290 |
| 105 | CDC42BPA | 0.50931094 |
| 106 | LATS2 | 0.50029898 |
| 107 | LRRK2 | 0.49998104 |
| 108 | IKBKE | 0.49397031 |
| 109 | PAK3 | 0.46178696 |
| 110 | IGF1R | 0.45851528 |
| 111 | MAPK3 | 0.45687456 |
| 112 | MAPKAPK3 | 0.45162579 |
| 113 | NTRK3 | 0.45013901 |
| 114 | SGK3 | 0.44819727 |
| 115 | MTOR | 0.44775201 |
| 116 | CAMKK1 | 0.44683885 |
| 117 | CDK9 | 0.44510895 |
| 118 | WNK1 | 0.44020846 |
| 119 | CAMK2G | 0.43628580 |
| 120 | CSF1R | 0.43564366 |
| 121 | STK38L | 0.43434294 |
| 122 | IRAK3 | 0.42786831 |
| 123 | MAP3K2 | 0.40356826 |
| 124 | CSK | 0.40000930 |
| 125 | MOS | 0.39352296 |
| 126 | PRKD3 | 0.38822166 |
| 127 | KSR1 | 0.38665564 |
| 128 | TRPM7 | 0.36288460 |
| 129 | STK38 | 0.36142891 |
| 130 | TBK1 | 0.35785254 |
| 131 | FGFR1 | 0.35373346 |
| 132 | SGK494 | 0.33841946 |
| 133 | SGK223 | 0.33841946 |
| 134 | PKN1 | 0.32909520 |
| 135 | CAMK1 | 0.31608640 |
| 136 | WNK4 | 0.30321801 |
| 137 | PTK2 | 0.29685176 |
| 138 | EPHA3 | 0.29364397 |
| 139 | ERBB2 | 0.28471274 |
| 140 | GRK6 | 0.27548345 |
| 141 | PRKACA | 0.26220516 |
| 142 | BMX | 0.25903995 |
| 143 | PRKG2 | 0.25795917 |
| 144 | CDK4 | 0.25714389 |
| 145 | STK11 | 0.24785520 |
| 146 | RPS6KA3 | 0.22381351 |
| 147 | MAP3K5 | 0.21257046 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.53293683 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.21266926 |
| 3 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.15472109 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.07357606 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.03070745 |
| 6 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.80576298 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.73852820 |
| 8 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.67008463 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.60982366 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.59356562 |
| 11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.54892949 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.44500671 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.36638587 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.30736627 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.27138228 |
| 16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.10318870 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.09778264 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.08834727 |
| 19 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.96704628 |
| 20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.95986908 |
| 21 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.95640601 |
| 22 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.93922184 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.75772710 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.74914171 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.74691080 |
| 26 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.65022431 |
| 27 | Carbon metabolism_Homo sapiens_hsa01200 | 1.60564967 |
| 28 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.58349396 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.58213743 |
| 30 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.52237376 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.50521616 |
| 32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.50379818 |
| 33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.49436037 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.48622721 |
| 35 | * Fat digestion and absorption_Homo sapiens_hsa04975 | 1.40592444 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.39657091 |
| 37 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.36814642 |
| 38 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.35659526 |
| 39 | * Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.32831350 |
| 40 | Retinol metabolism_Homo sapiens_hsa00830 | 1.28582259 |
| 41 | Bile secretion_Homo sapiens_hsa04976 | 1.25863474 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.24353240 |
| 43 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.21033648 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.16392347 |
| 45 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.15481069 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.14922227 |
| 47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.13516539 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 1.12458338 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.08728445 |
| 50 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.06898967 |
| 51 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.98831165 |
| 52 | Malaria_Homo sapiens_hsa05144 | 0.91502970 |
| 53 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.91378108 |
| 54 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.90152969 |
| 55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.85192008 |
| 56 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.84430213 |
| 57 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.80756718 |
| 58 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.77642867 |
| 59 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.77229509 |
| 60 | Lysine degradation_Homo sapiens_hsa00310 | 0.74890915 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.73910015 |
| 62 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.72291374 |
| 63 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.70325169 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68848768 |
| 65 | Sulfur relay system_Homo sapiens_hsa04122 | 0.68547374 |
| 66 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.67339328 |
| 67 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.64152741 |
| 68 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.63800262 |
| 69 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.62624231 |
| 70 | Insulin resistance_Homo sapiens_hsa04931 | 0.59254748 |
| 71 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.56730643 |
| 72 | Leishmaniasis_Homo sapiens_hsa05140 | 0.53519493 |
| 73 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48775706 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.47961821 |
| 75 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.45536806 |
| 76 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.44348215 |
| 77 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.43687157 |
| 78 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.39487178 |
| 79 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.39357395 |
| 80 | Pertussis_Homo sapiens_hsa05133 | 0.37977606 |
| 81 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.36619531 |
| 82 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.35190868 |
| 83 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.34870286 |
| 84 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.34732431 |
| 85 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.33677087 |
| 86 | Tuberculosis_Homo sapiens_hsa05152 | 0.33413794 |
| 87 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.32884848 |
| 88 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.32874052 |
| 89 | Other glycan degradation_Homo sapiens_hsa00511 | 0.31122599 |
| 90 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.31119745 |
| 91 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.27288521 |
| 92 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.25955268 |
| 93 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24323091 |
| 94 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.24272281 |
| 95 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.24008205 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | 0.23799154 |
| 97 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.23211461 |
| 98 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.22930448 |
| 99 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.21713259 |
| 100 | Phagosome_Homo sapiens_hsa04145 | 0.20232235 |
| 101 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.19952369 |
| 102 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.19258438 |
| 103 | Prion diseases_Homo sapiens_hsa05020 | 0.18088623 |
| 104 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.17114638 |
| 105 | Platelet activation_Homo sapiens_hsa04611 | 0.15846957 |
| 106 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.14674498 |
| 107 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.12682671 |
| 108 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.11375867 |
| 109 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.06630062 |
| 110 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.06117052 |
| 111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.05358457 |
| 112 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.01085841 |
| 113 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.1781146 |
| 114 | Mineral absorption_Homo sapiens_hsa04978 | -0.1780666 |
| 115 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1555844 |
| 116 | Amoebiasis_Homo sapiens_hsa05146 | -0.1517324 |
| 117 | Parkinsons disease_Homo sapiens_hsa05012 | -0.1419111 |
| 118 | Alzheimers disease_Homo sapiens_hsa05010 | -0.1141092 |
| 119 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.1048871 |
| 120 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0732916 |
| 121 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0604084 |
| 122 | Renin secretion_Homo sapiens_hsa04924 | -0.0571261 |
| 123 | One carbon pool by folate_Homo sapiens_hsa00670 | -0.0407324 |
| 124 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0328174 |
| 125 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0280357 |
| 126 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0058561 |
| 127 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0056975 |

